Monitoring of Risedronate by biochemical bone markers in clinical practice.

The study of trend of Risedronate 10 mg/day in menopausal women with a high level of resorptive bone marker (Betacrosslaps, CTx) by the following bone markers:Bone alkaline phosphatase (formation marker) total alkaline phosphatase (TAlP), NMID osteocalcin, undercarboxylated osteocalcin (UcOC) and pr...

Full description

Saved in:
Bibliographic Details
Main Author: Narong Bunyaratavej
Other Authors: Mahidol University
Format: Article
Published: 2018
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/16784
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University